[1]
M. H. Azhar, A. Rauf, F. U. R. Khan, M. Rizwan, M. L. Khan, and A. Wahaj, “Efficacy and Safety of Tailored Dose of BCG (40mg) Versus Standard Dose (80mg) Instillation Therapy in Non-Muscle Invasive Early Bladder Cancer Patients”, Biol Clin Sci Res J, vol. 6, no. 10, pp. 74–77, Oct. 2025.